Loading...
Market Growth Forecast: The U.S. Assisted Reproductive Technology (ART) market is projected to grow from $6.01 billion in 2024 to $9.31 billion by 2033, with a CAGR of 4.98% driven by rising infertility rates and advancements in reproductive technology.
Drivers of Market Expansion: Increased awareness about fertility treatments, campaigns promoting treatment options, and the acceptance of genetic testing and embryo freezing are key factors contributing to the growth of the ART market.
Technological Innovations: Advancements in AI and automation are enhancing IVF procedures, improving accuracy and efficiency, while the growing trend of egg freezing reflects changing social norms and increased fertility preservation options for women.
Challenges Faced: High treatment costs and regulatory hurdles present significant challenges for the ART market, limiting access to services for many individuals and creating disparities in reproductive healthcare.
